Our Focus
We seek opportunities to meaningfully transform, expand, and increase economic productivity in balance with the natural world.

Vast data from low-cost, high-throughput sequencing and metagenomics, new computational and analysis tools, and development of precision gene editing systems accelerate the scaleup of cell and gene therapies and will soon usher in an era of truly personalized medicine. Machine learning and artificial intelligence increasingly predict and design biology, leading to efficient small-molecule drug discovery, proteins and biologics designed on-demand in-silico, increased automation, and Large Language Models and other multimodal tools. The transformational sectors include therapeutics, diagnostics, software and tools.

As technology gets faster, smaller and cheaper, we will move from large, centralized, high-carbon factories to flexible, decentralized, efficient in-home systems. Abundant energy will unlock new manufacturing methods: Electrified, automated, AI-driven machines will replace conventional mining, agriculture, manufacturing, and human labor. Carbon will become an economic resource, rather than a byproduct. Cells and enzymes will function as machines, enabling biomanufacturing and the dismantling of 19th century Industrial Revolutions. We will engineer our world with stated intent, while living organisms execute for us.